Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Open Access
- 1 April 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 20 (4), 705-711
- https://doi.org/10.1681/asn.2007111207
Abstract
Patients with chronic kidney disease (CKD) have an increased risk for cardiovascular morbidity and mortality. Little attention has been paid to the problem of atrial fibrillation, although this arrhythmia is very frequent with a prevalence of 13 to 27% in patients on long-term hemodialysis. Because of the large number of pathophysiologic mechanisms involved, these patients have a high risk for both thromboembolic events and hemorrhagic complications. Stroke is a frequent complication in CKD: The US Renal Data System reports an incidence of 15.1% in hemodialysis patients compared with 9.6% in patients with other stages of CKD and 2.6% in a control cohort without CKD. The 2-yr mortality rates after stroke in these subgroups were 74, 55, and 28%, respectively. Although oral coumadin is the treatment of choice for atrial fibrillation, its use in patients with CKD is reported only in limited studies, all in hemodialysis patients, and is associated with a markedly increased rate of bleeding compared with patients without CKD. With regard to the high risk for stroke and the conflicting data about oral anticoagulation, an individualized stratification algorithm is presented based on relevant studies.Keywords
This publication has 43 references indexed in Scilit:
- Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rulesThrombosis and Haemostasis, 2007
- Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular DiseaseCirculation, 2006
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm SocietyJournal of the American College of Cardiology, 2006
- Chronic Kidney Disease in the Developing WorldThe New England Journal of Medicine, 2006
- Frequency of atrial fibrillation and factors related to its development in dialysis patientsInternational Journal of Cardiology, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004
- Serious adverse incidents with the usage of low molecular weight heparins in patients with chronic kidney diseaseAmerican Journal of Kidney Diseases, 2004
- Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?International Journal of Cardiology, 2003
- Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventionsKidney International, 2003